Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Functionality Changes Associated With Patients Who Were Taking Short Acting Opioids Chronically and Who Initiated Treatment With Duragesic® (Fentanyl Transdermal System) for the Management of Chronic Low Back Pain.

NCT00237341 is registered in ClinicalTrials.gov with PriCara, Unit of Ortho-McNeil, Inc. as lead sponsor.

NCT NCT00237341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Functionality Changes Associated With Patients Who Were Taking Short Acting Opioids Chronically and Who Initiated Treatment With Duragesic® (Fentanyl Transdermal System) for the Management of Chronic Low Back Pain.
Lead sponsor
PriCara, Unit of Ortho-McNeil, Inc.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2002
Completion date
January 31, 2004
Enrollment
358 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain